Quantifying ERK-activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling (2021)

First Author: Hamis S

Attributed to: Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.20.440559

Publication URI: http://dx.doi.org/10.1101/2021.04.20.440559

Type: Preprint